ANXA5 and metabolic dysfunction-associated steatotic liver disease: JUN, TLR4 (42), EGFR (43), and TNF (44) were confirmed to promote the progression of NAFLD in previous studies, while ANXA5 (45) and PTEN (46) were identified as protective factors.